Physician profile
Wilbert A Cusano
NPI 1487696860
$518.38
in general payments reported to CMS, 2019-2025
10 companies · $138 in 2025
The $138 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.33 · 2020: $50.65 · 2021: $36.13 · 2022: $48.76 · 2023: $97.65 · 2024: $108 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $213.31 | 2019-2025 | Bridion |
| Pacira Pharmaceuticals Incorporated | $106.87 | 2022-2025 | Exparel, Iovera |
| Becton, Dickinson and Company | $48.04 | 2025 | Hemosphere |
| Boston Scientific Corporation | $29.04 | 2023 | Watchman Access System |
| Portola Pharmaceuticals, LLC | $26.75 | 2020 | |
| Icu Medical INC | $25.94 | 2024 | Pivc |
| Heron Therapeutics, INC. | $18.16 | 2023 | Aponvie |
| Teleflex LLC | $17.54 | 2024 | Rusch |
| Ge Healthcare | $16.83 | 2025 | |
| Acacia Pharma INC | $15.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilbert Cusano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.